Study #2022-0170
TRIP-Treatment to improve depression and/or anxiety using psilocybin-assisted sychotherapy in patients with advanced cancer on maintenance therapy
MD Anderson Study Status
Enrolling
Treatment Agent
Psilocybin
Description
To learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy on depression and/or anxiety in participants who are being treated for advanced cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Depression, Anxiety, Psilocybin-Assisted Psychotherapy, Advanced Cancer
Study phase:
Phase II
Physician name:
Moran Amit
Department:
Head & Neck Surgery
For general questions about clinical trials:
1-855-776-1559
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.